ALEXANDRIA REAL ESTATE EQUIT (ARE) Stock Overview
USA - NYSE:ARE - US0152711091 - REIT
ARE Key Statistics, Chart & Performance
The current stock price of ARE is 77.41 USD. In the past month the price decreased by -7.68%. In the past year, price decreased by -31.51%.
ARE Latest News, Press Relases and Analysis
ARE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL | WELLTOWER INC | 100.53 | 119.01B | ||
| VTR | VENTAS INC | 163.7 | 31.99B | ||
| DOC | HEALTHPEAK PROPERTIES INC | 32.34 | 13.04B | ||
| OHI | OMEGA HEALTHCARE INVESTORS | 23.96 | 11.94B | ||
| CTRE | CARETRUST REIT INC | 28.59 | 7.85B | ||
| AHR | AMERICAN HEALTHCARE REIT INC | N/A | 7.47B | ||
| HR | HEALTHCARE REALTY TRUST INC | N/A | 6.56B | ||
| SBRA | SABRA HEALTH CARE REIT INC | 23.79 | 4.34B | ||
| DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.33B | ||
| DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.12B | ||
| NHI | NATL HEALTH INVESTORS INC | 25.14 | 3.57B | ||
| MPW | MEDICAL PROPERTIES TRUST INC | N/A | 3.08B |
Related stock screener links
About ARE
Company Profile
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Company Info
ALEXANDRIA REAL ESTATE EQUIT
26 North Euclid Avenue
Pasadena CALIFORNIA 91101 US
CEO: Stephen A. Richardson
Employees: 552
Phone: 16265780777
ALEXANDRIA REAL ESTATE EQUIT / ARE FAQ
What does ARE do?
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Can you provide the latest stock price for ALEXANDRIA REAL ESTATE EQUIT?
The current stock price of ARE is 77.41 USD. The price increased by 0.65% in the last trading session.
Does ARE stock pay dividends?
ALEXANDRIA REAL ESTATE EQUIT (ARE) has a dividend yield of 6.87%. The yearly dividend amount is currently 5.22.
What is the ChartMill rating of ALEXANDRIA REAL ESTATE EQUIT stock?
ARE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is ALEXANDRIA REAL ESTATE EQUIT (ARE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ARE.
Is ALEXANDRIA REAL ESTATE EQUIT (ARE) expected to grow?
The Revenue of ALEXANDRIA REAL ESTATE EQUIT (ARE) is expected to decline by -3.45% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for ARE stock?
ALEXANDRIA REAL ESTATE EQUIT (ARE) currently has 552 employees.
ARE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ARE. When comparing the yearly performance of all stocks, ARE is a bad performer in the overall market: 86.96% of all stocks are doing better.
ARE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ARE. ARE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
ARE Financial Highlights
Over the last trailing twelve months ARE reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS decreased by -116.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.06% | ||
| ROE | -0.12% | ||
| Debt/Equity | 0.77 |
ARE Forecast & Estimates
19 analysts have analysed ARE and the average price target is 98.77 USD. This implies a price increase of 27.59% is expected in the next year compared to the current price of 77.41.
For the next year, analysts expect an EPS growth of -84.18% and a revenue growth -3.45% for ARE